⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MBOT News
Microbot Medical, Inc. Common Stock
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
globenewswire.com
MBOT
Form 8-K
sec.gov
MBOT
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
globenewswire.com
MBOT
Form 8-K
sec.gov
MBOT
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
globenewswire.com
MBOT
Form 8-K
sec.gov
MBOT
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
globenewswire.com
MBOT
Form 8-K
sec.gov
MBOT
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)
globenewswire.com
MBOT
Form 8-K
sec.gov
MBOT